Literature DB >> 17763990

Studies of the molecular mechanisms of action of relaxin on the adenylyl cyclase signaling system using synthetic peptides derived from the LGR7 relaxin receptor.

A O Shpakov1, I A Gur'yanov, L A Kuznetsova, S A Plesneva, E A Shpakova, G P Vlasov, M N Pertseva.   

Abstract

The peptide hormone relaxin produces dose-dependent stimulation of adenylyl cyclase activity in rat tissues (striatum, cardiac and skeletal muscle) and the muscle tissues of invertebrates, i.e., the bivalve mollusk Anodonta cygnea and the earthworm Lumbricus terrestris, adenylyl cyclase stimulation being more marked in the rat striatum and cardiac muscle. Our studies of the type of relaxin receptor involved in mediating these actions of relaxin involved the first synthesis of peptides 619-629, 619-629-Lys(Palm), and 615-629, which are derivatives of the primary structure of the C-terminal part of the third cytoplasmic loop of the type 1 relaxin receptor (LGR7). Peptides 619-629-Lys(Palm) and 615-629 showed competitive inhibition of adenylyl cyclase stimulation by relaxin in rat striatum and cardiac muscle but had no effect on the action of relaxin in rat skeletal muscle or invertebrate muscle, which is evidence for the tissue and species specificity of their actions. On the one hand, this indicates involvement of the LGR7 receptor in mediating the adenylyl cyclase-stimulating action of relaxin in rat striatum and cardiac muscle and, on the other, demonstrates the existence of other adenylyl cyclase signal mechanisms for the actions of relaxin in rat skeletal muscle and invertebrate muscle, not involving LGR7 receptors. The adenylyl cyclase-stimulating effect of relaxin in the striatum and cardiac muscles was found to be decreased in the presence of C-terminal peptide 385-394 of the alpha(s) subunit of the mammalian G protein and to be blocked by treatment of membranes with cholera toxin. These data provide evidence that in the striatum and cardiac muscle, relaxin stimulates adenylyl cyclase via the LGR7 receptor, this being functionally linked with G(s) protein. It is also demonstrated that linkage of relaxin-activated LGR7 receptor with the G(s) protein is mediated by interaction of the C-terminal half of the third cytoplasmic loop of the receptor with the C-terminal segment of the alpha(s) subunit of the G protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763990     DOI: 10.1007/s11055-007-0071-y

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  39 in total

1.  An improved method for the preparation of synaptosomal fractions in high purity.

Authors:  F Hajós
Journal:  Brain Res       Date:  1975-08-15       Impact factor: 3.252

2.  A novel, adenylate cyclase, signaling mechanism of relaxin H2 action.

Authors:  Alexander Shpakov; Marianna Pertseva; Ludmila Kuznetsova; Svetlana Plesneva
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

3.  Signal switching after stimulation of LGR7 receptors by human relaxin 2.

Authors:  Michelle L Halls; Ross A Bathgate; Roger J Summers
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

Review 4.  [Use of the peptide strategy to study mechanisms of transferring the hormone signal to the cell].

Authors:  A O Shpakov; M N Pertseva
Journal:  Zh Evol Biokhim Fiziol       Date:  2005 Sep-Oct

5.  Rhodopsin recognition by mutant G(s)alpha containing C-terminal residues of transducin.

Authors:  M Natochin; K G Muradov; R L McEntaffer; N O Artemyev
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

6.  Isolation and properties of skeletal muscle plasma membrane.

Authors:  A M Kidwai; M A Radcliffe; E Y Lee; E E Daniel
Journal:  Biochim Biophys Acta       Date:  1973-03-29

Review 7.  Recent progress in relaxin-3-related research.

Authors:  Changlu Liu; Pascal Bonaventure; Steven W Sutton; Jingcai Chen; Chester Kuei; Diane Nepomuceno; Timothy W Lovenberg
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

8.  Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity.

Authors:  O Bartsch; B Bartlick; R Ivell
Journal:  Mol Hum Reprod       Date:  2001-09       Impact factor: 4.025

9.  Comparative study of biological activity of insulins of lower vertebrates in the novel adenylyl cyclase test-system.

Authors:  L Kuznetsova; A Shpakov; Yu Rusakov; S Plesneva; V Bondareva; M Pertseva
Journal:  Regul Pept       Date:  2003-11-15

10.  Involvement of the adenylyl cyclase signaling system in the action of insulin and mollusk insulin-like peptide.

Authors:  M N Pertseva; S A Plesneva; A O Shpakov; L A Kuznetsova
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1995-12       Impact factor: 2.231

View more
  10 in total

1.  Biological activity in vitro and in vivo of peptides corresponding to the third intracellular loop of thyrotropin receptor.

Authors:  E A Shpakova; A O Shpakov; O V Chistyakova; I V Moyseyuk; K V Derkach
Journal:  Dokl Biochem Biophys       Date:  2012-05-05       Impact factor: 0.788

2.  Biological activity of lipophilic derivatives of peptide 562-572 of rat luteinizing hormone receptor.

Authors:  E A Shpakova; K V Derkach; A O Shpakov
Journal:  Dokl Biochem Biophys       Date:  2013-10-23       Impact factor: 0.788

Review 3.  Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.

Authors:  Michelle L Halls
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Peptides corresponding to intracellular regions of somatostatin receptors with agonist and antagonist activity.

Authors:  E A Shpakova; A O Shpakov
Journal:  Dokl Biochem Biophys       Date:  2011-05-18       Impact factor: 0.788

Review 5.  Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development.

Authors:  Katie O'Callaghan; Athan Kuliopulos; Lidija Covic
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 6.  Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.

Authors:  Sarah L Tressel; Georgios Koukos; Boris Tchernychev; Suzanne L Jacques; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2011

Review 7.  [Novel achievements in development and application of GPCR-peptides].

Authors:  A O Shpakov; K V Derkach
Journal:  Zh Evol Biokhim Fiziol       Date:  2015 Jan-Feb

Review 8.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

9.  Signal protein-derived peptides as functional probes and regulators of intracellular signaling.

Authors:  Alexander O Shpakov
Journal:  J Amino Acids       Date:  2011-08-23

Review 10.  The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.

Authors:  Ting-Yun Chen; Xiaoyun Li; Ching-Hsia Hung; Harinath Bahudhanapati; Jiangning Tan; Daniel J Kass; Yingze Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-02-26       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.